Abstract
Biotechnology, the surging wave of economic development in the world, prompted Newly Industrialised Economies (NIEs) in Asia to emulate developed countries in biotechnology development. The stakes are however high and the uncertainty about return on investment has provoked a careful assessment of national scientific and technological strengths. With a focus on Hong Kong, Singapore, and Taiwan, this paper reviews the current market conditions and key factors that may advantage the development of biotechnology industry in the NIEs. It is argued that co-evolution of scientific and technology capabilities are essential, and the NIEs will have to leverage their comparative advantages in technological capabilities and should focus on core competencies in the already locally established biotechnology areas.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
